Lydia Veratti
Psychiatric/Mental Health · Glendale, AZNPI 1508227687
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 531 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 531 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$789
- Corium, LLC$726
- Otsuka America Pharmaceutical, Inc.$648
- Neurocrine Biosciences, Inc.$613
- Vanda Pharmaceuticals Inc.$502
- plus $4K from 19 others
What the payments were for
- Food & beverage$8,69499%
- Education$731%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 186 | $1,934 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $789 |
| Corium, LLC | 40 | $726 |
| Otsuka America Pharmaceutical, Inc. | 30 | $648 |
| Neurocrine Biosciences, Inc. | 33 | $613 |
| Vanda Pharmaceuticals Inc. | 19 | $502 |
| Almatica Pharma LLC | 21 | $459 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $414 |
| Alkermes, Inc. | 15 | $380 |
| Axsome Therapeutics, Inc. | 16 | $376 |
| Lundbeck LLC | 21 | $360 |
| Supernus Pharmaceuticals, Inc. | 21 | $311 |
| Ironshore Pharmaceuticals Inc. | 13 | $271 |
| Tris Pharma Inc | 13 | $254 |
| Sunovion Pharmaceuticals Inc. | 17 | $227 |
| Bausch Health US, LLC | 7 | $120 |
| Johnson & Johnson | 5 | $115 |
| Idorsia Pharmaceuticals US Inc | 5 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Noven Therapeutics, LLC | 2 | $40 |
| Alfasigma USA, Inc. | 2 | $34 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
How this compares
$8,767 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 43 | $1,049 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $395 |
| Buspirone Hcl | 18 | $274 |
| Propranolol Hcl | 16 | $165 |
| Ziprasidone Hcl | 13 | $161 |
| Lamotrigine | 26 | $153 |
| Bupropion Hcl SrBupropion Hcl | 15 | $116 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $91 |
| Trazodone Hcl | 11 | $73 |
| Metformin Hcl ErMetformin Hcl | 11 | $44 |
| Clonazepam | 12 | $26 |
| Alprazolam | 19 | $23 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Glendale
- Barbara KayiiraGlendale$10K
- Curtis AndrewsGlendale$9K
- Lizy WindsorGlendale$8K
- Sarbjit SinghGlendale$6K
- Elizabeth ElliottPhoenix$363K
- Diane StrickerGilbert$281K
- Russell HorningPhoenix$254K
- Stacy UnderwoodMesa$252K
- Brett LeifsonScottsdale$90K
- Claire ReecePhoenix$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.